4.Waselenko, JK, MacVittie, TJ, Blakely, WFStrategic National Stockpile Radiation Working Group. Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med. 2004;140 (12):1037–1051.
5.Gorin, NC, Fliedner, TM, Gourmelon, P.Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents. Ann Hematol. 2006;85 (10):671–679.
7.Schünemann, HJ, Oxman, AD, Brozek, JGRADE Working Group. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336 (7653):1106–1110.
9.Maurer, DC.Nuclear detection: preliminary observations on the Domestic Nuclear Detection Office's efforts to develop a global nuclear detection architecture. Testimony before the Committee on Homeland Security and Governmental Affairs, US Senate. http://www.gao.gov/products/GAO-08-999T. Published July 16, 2008. Accessed June 10, 2011.
10.Mowatt-Larssen, R.Nuclear terrorism and the 21st century. Statement before the Homeland Security and Governmental Affairs Committee, United States Senate. hsgac.senate.gov/public/_files/040208MowattLarssen.pdf. Published April 2, 2008. Accessed June 10, 2011.
11.Mettler, FA Jr, Voelz, GL.Major radiation exposure—what to expect and how to respond. N Engl J Med. 2002;346 (20):1554–1561.
12.Mettler, FA, Upton, AC.Deterministic effects of ionizing radiation. In: Mettler FA, Upton AC, eds. Medical Effects of Radiation. 3rd ed. Philadelphia: Saunders Elsevier; 2008.
14.Meineke, V, Fliedner, TM.Radiation-induced multi-organ involvement and failure: challenges for radiation accident medical management and future research. BJR Suppl. 2005;27:196–200.
15.Gourmelon, P, Marquette, C, Agay, D, Mathieu, J, Clarençon, D.Involvement of the central nervous system in radiation-induced multi-organ dysfunction and/or failure. BJR Suppl. 2005;27:62–68.
16.Jackson, WL Jr, Gallagher, C, Myhand, RC, Waselenko, JK.Medical management of patients with multiple organ dysfunction arising from acute radiation syndrome. BJR Suppl. 2005;27:161–168.
17.Warren, S, Bowers, JZ.The acute radiation syndrome in man. Ann Intern Med. 1950;32 (2):207–216.
18.Brooks, JW, Evans, EI, Ham, WT Jr, Reid, JD.The influence of external body radiation on mortality from thermal burns. Ann Surg. 1952;136 (3):533–545.
19.Ledney, GD, Elliot, TB, Moore, MM.Modulations of mortality by tissue trauma and sepsis in mice after radiation injury. In: Mossman KL, Mills WA, eds. The Biological Basis of Radiation Protection Practices. Baltimore, MD: Williams & Wilkins; 1992:202-217.
20.Alexander, GA, Swartz, HM, Amundson, SA.BiodosEPR-2006 Meeting: acute dosimetry consensus committee recommendations on biodosimetry applications in events involving uses of radiation by terrorists and accidents. Radiat Meas. 2007;42(Suppl)972–996.
22.Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation. Health Risks From Exposure to Low Levels of Ionizing Radiation, BEIR VII Phase 2.Washington, DC: National Academies Press; 2006:267-312.
23.Anno, GH, Young, RW, Bloom, RM, Mercier, JR.Dose response relationships for acute ionizing-radiation lethality. Health Phys. 2003;84 (5):565–575.
24.Bender, MA, Gooch, PC.Somatic chromosome aberrations induced by human whole-body irradiation: the “Recuplex” criticality accident. Radiat Res. 1966;29 (4):568–582.
25.Goans, RE, Holloway, EC, Berger, ME, Ricks, RC.Early dose assessment in criticality accidents. Health Phys. 2001;81 (4):446–449.
26.Demidenko, E, Williams, BB, Swartz, HM.Radiation dose prediction using data on time to emesis in the case of nuclear terrorism. Radiat Res. 2009;171 (3):310–319.
27.Fliedner, TM, Friesecke, I, Beyrer, K.Medical Management of Radiation Accidents: Manual on Acute Radiation Syndrome. Oxford, UK: British Institute of Radiobiology; 2001.
28.Wilkins, RC, Romm, H, Kao, TC.Interlaboratory comparison of the dicentric chromosome assay for radiation biodosimetry in mass casualty events. Radiat Res. 2008;169 (5):551–560.
29.Lloyd, DC, Edwards, AA, Moquet, JE, Guerrero-Carbajal, YC.The role of cytogenetics in early triage of radiation casualties. Appl Radiat Isot. 2000;52 (5):1107–1112.
30.Wojcik, A, Lloyd, D, Romm, H, Roy, L.Biological dosimetry for triage of casualties in a large-scale radiological emergency:capacity of the EU member states. Radiat Prot Dosimetry. 2010;138 (4):397–401.
31.Parker, DD, Parker, JC.Estimating radiation dose from time to emesis and lymphocyte depletion. Health Phys. 2007;93 (6):701–704.
32.Flynn, DF, Goans, RE.Nuclear terrorism: triage and medical management of radiation and combined-injury casualties. Surg Clin North Am. 2006;86 (3):601–636.
33.Andrews, GA.Medical management of accidental total-body irradiation. In: Hubner K, Fry S, eds. Medical Basis for Radiation Accident Preparedness. New York: Elsevier Press; 1980.
34.Blakely, WF, Ossetrova, NI, Manglapus, GL.Amylase and blood cell-count hematological radiation-injury biomarkers in a rhesus monkey radiation model-use of multiparameter and integrated biological dosimetry. Radiat Meas. 2007;42(Suppl)1164–1170.
35.Dainiak, N, Berger, P, Albanese, J.Relevance and feasibility of multi-parameter assessment for management of mass casualties from a radiological event. Exp Hematol. 2007;35 4(Suppl 1)17–23.
36.Monti, P, Wysocki, J, van der Meeren, A, Griffiths, NM.The contribution of radiation-induced injury to the gastrointestinal tract in the development of multi-organ dysfunction syndrome or failure. BJR Suppl. 2005;27(Suppl)89–94.
37.Hauer-Jensen, M, Kumar, KS, Wang, J.Intestinal toxicity in radiation- and combined injury: significance, mechanisms, and countermeasures. In: Larche RA, ed. Global Terrorism Issues and Developments. Hauppauge, NY: Nova Science Publishers; 2008.
38.Pizzarello, DJ, Witcofski, TL.Medical Radiation Biology. Philadelphia: Lea & Febiger.; 1982.
39.Lushbaugh, CC.The impact of estimates on radiation emergency management. Proceedings of a Symposium on the Control of Exposure of Public to Ionizing Radiation in the Event of Accident or Attack. National Council on Radiation Protection and Measurement, held on April 27-28, 1981, in Bethesda, Md; 1982; pp 46-47.
40.Dainiak, N, Waselenko, JK, Armitage, JO.The hematologist and radiation casualties. Hematology Am Soc Hematol Educ Progr; 2003:473-496.
41.Sigsgaard, T, Herrstedt, J, Handberg, J, Kjaer, M, Dombernowsky, P.Ondansetron plus metopimazine compared with ondansetron plus metopimazine plus prednisolone as antiemetic prophylaxis in patients receiving multiple cycles of moderately emetogenic chemotherapy. J Clin Oncol. 2001;19 (7):2091–2097.
42.Schmoll, HJ, Aapro, MS, Poli-Bigelli, S.Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment. Ann Oncol. 2006;17 (6):1000–1006.
43.Walsh, T, Morris, AK, Holle, LM.Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial. Bone Marrow Transplant. 2004;34 (11):963–968.
44.Abdelsayed, GG.Management of radiation-induced nausea and vomiting. Exp Hematol. 2007;35 4(Suppl 1)34–36.
45.Roila, F, Hesketh, PJ, Herrstedt, JAntiemetic Subcommitte of the Multinational Association of Supportive Care in Cancer. Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol. 2006;17 (1):20–28.
46.Kris, MG, Hesketh, PJ, Somerfield, MRAmerican Society of Clinical Oncology. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol. 2006;24 (18):2932–2947.
47.Harris, AG, O’Dorisio, TM, Woltering, EADiarrhea Management Consensus Development Panel. Consensus statement: octreotide dose titration in secretory diarrhea. Dig Dis Sci. 1995;40 (7):1464–1473.
48.Wadler, S, Benson, AB III, Engelking, C.Recommended guidelines for the treatment of chemotherapy-induced diarrhea. J Clin Oncol. 1998;16 (9):3169–3178.
49.Ippoliti, C.Antidiarrheal agents for the management of treatment-related diarrhea in cancer patients. Am J Health Syst Pharm. 1998;55 (15):1573–1580.
50.Szilagyi, A, Shrier, I.Systematic review: the use of somatostatin or octreotide in refractory diarrhoea. Aliment Pharmacol Ther. 2001;15 (12):1889–1897.
51.Yavuz, MN, Yavuz, AA, Aydin, F, Can, G, Kavgaci, H.The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study. Int J Radiat Oncol Biol Phys. 2002;54 (1):195–202.
52.Hermsen, JL, Sano, Y, Kudsk, KA.Food fight! Parenteral nutrition, enteral stimulation and gut-derived mucosal immunity. Langenbecks Arch Surg. 2009;394 (1):17–30.
53. McClave, SA, Martindale, RG, Vanek, VWA.S.P.E.N. Board of Directors; American College of Critical Care Medicine; Society of Critical Care Medicine. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2009;33 (3):277–316.
54.Worthington, P, Gilbert, KA, Wagner, BA.Parenteral nutrition for the acutely ill. AACN Clin Issues. 2000;11 (4):559–579, quiz 634-636.
55.International Atomic Energy Agency. IAEA reports on Tokaimura accident. Health Phys. 2000;78 (2):231.
56.Meineke, V.Medical and Organization Challenges Resulting From a Radiological Nuclear Emergency. Acute Radiation Syndrome of the Skin: New Aspects in Pathophysiology and Treatments Following Radiation Exposure. Washington, DC: Radiation Injury Treatment Network; 2007.
57.Hoashi, T, Okochi, H, Kadono, T.A case of acute radiation syndrome from the dermatological aspect. Br J Dermatol. 2008;158 (3):597–602.
58.Peter, RU.Klinische Aspekte des kutanen Strahlensyndroms nach Strahlenunfallen—Erfahrungen von Goiania und Tschernobyl. Akuel Dermatol. 1993;19:364–367.
59.Peter, RU.The cutaneous radiation syndrome. In: MacVittie TJ, Weiss JF, Browne D, eds. Advances in the Treatment of Radiation Injuries. Oxford, UK: Elsevier; 1999.
60.Goldschmidt, H.Dermatologic roentgen therapy and radiocarcinogenesis. Hautarzt. 1982;33 (4):183–190.
61.Müller, K, Meineke, V.Radiation-induced alterations in cytokine production by skin cells. Exp Hematol. 2007;35 4(Suppl 1)96–104.
62.Meineke, V, van Beuningen, D, Sohns, T, Fliedner, TM.Medical management principles for radiation accidents. Mil Med. 2003;168 (3):219–222.
63.Meineke, V.The role of damage to the cutaneous system in radiation-induced multi-organ failure. BJR Suppl. 2005;27:85–99.
64.Roy, L, Bertho, JM, Souidi, M, Vozenin, MC, Voisin, P, Benderitter, M.Biochemical approach to prediction of multiple organ dysfunction syndrome. BJR Suppl. 2005;27:146–151.
65.Bertho, JM, Roy, L, Souidi, M.New biological indicators to evaluate and monitor radiation-induced damage: an accident case report. Radiat Res. 2008;169 (5):543–550.
66.Berger, ME, Christensen, DM, Lowry, PC, Jones, OW, Wiley, AL.Medical management of radiation injuries: current approaches. Occup Med (Lond). 2006;56 (3):162–172.
67.Chambers, JA, Purdue, GF.Radiation injury and the surgeon. J Am Coll Surg. 2007;204 (1):128–139.
68.Orgill, DP.Excision and skin grafting of thermal burns. N Engl J Med. 2009;360 (9):893–901.
69.Foster, K, Greenhalgh, D, Gamelli, RLFS 4IU VH S/D Clinical Study Group. Efficacy and safety of a fibrin sealant for adherence of autologous skin grafts to burn wounds: results of a phase 3 clinical study. J Burn Care Res. 2008;29 (2):293–303.
70.Brown, JB, McDOWELL, F, Fryer, MP.Surgical treatment of radiation burns. Surg Gynecol Obstet. 1949;88 (5):609–622.
71.Berger, ME, Hurtado, R, Dunlap, J.Accidental radiation injury to the hand: anatomical and physiological considerations. Health Phys. 1997;72 (3):343–348.
72.Geraci, JP, Mariano, MS, Jackson, KL, Taylor, DA, Still, ER.Effects of dexamethasone on late radiation injury following partial-body and local organ exposures. Radiat Res. 1992;129 (1):61–70.
73.DiCarlo, AL, Hatchett, RJ, Kaminski, JM.Medical countermeasures for radiation combined injury: radiation with burn, blast, trauma and/or sepsis. report of an NIAID Workshop, March 26-27, 2007. Radiat Res. 2008;169 (6):712–721.
74.Peter, RU, Gottlöber, P.Management of cutaneous radiation injuries: diagnostic and therapeutic principles of the cutaneous radiation syndrome. Mil Med. 2002;167 2(Suppl)110–112.
75.Ashcroft, GS, Greenwell-Wild, T, Horan, MA, Wahl, SM, Ferguson, MW.Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol. 1999;155 (4):1137–1146.
76.Tattini, C, Manchio, J, Zaporojan, V.Role of TGF-beta and FGF in the treatment of radiation-impaired wounds using a novel drug delivery system. Plast Reconstr Surg. 2008;122 (4):1036–1045.
77.François, S, Bensidhoum, M, Mouiseddine, M.Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells. 2006;24 (4):1020–1029.
78.Lataillade, JJ, Doucet, C, Bey, E.New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med. 2007;2 (5):785–794.
79.Chapel, A, Bertho, JM, Bensidhoum, M.Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med. 2003;5 (12):1028–1038.
80.Miuram, M, Miura, Y, Padilla-Nash, HM.Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells. 2006;24 (4):1095–1103.
81.Pittenger, MF, Mackay, AM, Beck, SC.Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284 (5411):143–147.
82.Uccelli, A, Moretta, L, Pistoia, V.Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8 (9):726–736.
83.Nauta, AJ, Fibbe, WE.Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110 (10):3499–3506.
84.Le Blanc, K, Samuelsson, H, Gustafsson, B.Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia. 2007;21 (8):1733–1738.
85.Le Blanc, K, Frassoni, F, Ball, LDevelopmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371 (9624):1579–1586.
86.Ball, LM, Bernardo, ME, Roelofs, H.Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood. 2007;110 (7):2764–2767.
87.Doucet, C, Ernou, I, Zhang, Y.Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol. 2005;205 (2):228–236.
88.Anno, GH, Baum, SJ, Withers, HR, Young, RW.Symptomatology of acute radiation effects in humans after exposure to doses of 0.5-30 Gy. Health Phys. 1989;56 (6):821–838.
89.Prasad, KN.Radiation damage to the nervous system. In: Prasad KN, ed. Handbook of Radiobiology. 2nd ed. Boca Raton, FL: CRC Press; 1995:161-170.
90.Walker, RI, Cerveny, RJ.Medical Consequences of Nuclear Warfare. Falls Church, VA: Office of the Surgeon General; 1989.
91.Cancer Pain Relief. 2nd ed. Geneva: World Health Organization; 1996.
92.TMT Handbook Consortium. Triage, monitoring and treatment of people exposed to ionizing radiation after a malevolent act. http://www.tmthandbook.org. Accessed July 2, 2009.
93.Collins, DL.Behavioral differences of irradiated persons associated with the Kyshtym, Chelyabinsk, and Chernobyl nuclear accidents. Mil Med. 1992;157 (10):548–552.
94.Cornely, OA, Maertens, J, Winston, DJ.Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007;356 (4):348–359.
95.Maekawa, K.Overview of medical care for highly exposed victims in Tokaimura accident. In: Ricks RC, Berger ME, O’Hara FM, eds. The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims. Boca Raton, FL: Partheon Publishing Group; 2002:313-318.
96.Asano, S.Multi-organ involvement: lessons from the experience of one victim of the Tokai-mura criticality accident. BJR Suppl. 2005;27:9–12.
97.Dainiak, N.Hematologic consequences of exposure to ionizing radiation. Exp Hematol. 2002;30 (6):513–528.
98.Dellinger, RP, Levy, MM, Carlet, JMInternational Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36 (1):296–327.
99.Akashi, M.Role of infection and bleeding in multiple organ involvement and failure. BJR Suppl. 2005;27:69–74.
100.Hirama, T, Tanosaki, S, Kandatsu, S.Initial medical management of patients severely irradiated in the Tokai-mura criticality accident. Br J Radiol. 2003;76 (904):246–253.
101.Crawford, SW.Diagnosis and management of pulmonary problems associated with radiation injury. In: Ricks RC, Berger ME, O’Hara FM, eds. The Medical Basis for Radiation Accident Preparedeness: The Clinical Care of Victims. Boca Raton, FL: Parthenon Publishing Group; 2002:131-138.
102.Ghafoori, P, Marks, LB, Vujaskovic, Z, Kelsey, CR.Radiation-induced lung injury. Assessment, management, and prevention. Oncology (Williston Park). 2008;22 (1):37–47, discussion 52-53.
103.Johnston, AM.Pulmonary effects of combined blast injury and radiation poisoning. J R Army Med Corps. 2004;150 3(Suppl 1)22–26.
104.Mefferd, JM, Donaldson, SS, Link, MP.Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys. 1989;16 (3):679–685.
105.The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342 (18):1301–1308.
106.Manthous, CA, Jackson, WL JrThe 9-11 Commission's invitation to imagine: a pathophysiology-based approach to critical care of nuclear explosion victims. Crit Care Med. 2007;35 (3):716–723.
107.Barrett, A, Depledge, MH, Powles, RL.Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation. Int J Radiat Oncol Biol Phys. 1983;9 (7):1029–1033.
108.Depledge, MH, Barrett, A, Powles, RL.Lung function after bone marrow grafting. Int J Radiat Oncol Biol Phys. 1983;9 (2):145–151.
109.Mancebo, J, Fernández, R, Blanch, L.A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 2006;173 (11):1233–1239.
110.Villar, J, Pérez-Méndez, L, López, JHELP Network. An early PEEP/FIO2 trial identifies different degrees of lung injury in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2007;176 (8):795–804.
111.Annane, D, Sébille, V, Charpentier, C.Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288 (7):862–871.
112.Briegel, J, Forst, H, Haller, M.Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med. 1999;27 (4):723–732.
113.Ishii, T, Futami, S, Nishida, M.Brief note and evaluation of acute-radiation syndrome and treatment of a Tokai-mura criticality accident patient. J Radiat Res (Tokyo). 2001;42(Suppl)S167–S182.
114.Akashi, M, Hirama, T, Tanosaki, S.Initial symptoms of acute radiation syndrome in the JCO criticality accident in Tokai-mura. J Radiat Res (Tokyo). 2001;42(Suppl)S157–S166.
115.Brook, AD, Ahrens, TS, Schaiff, R.Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med. 1999;27 (12):2609–2615.
116.D’Amico, R, Pifferi, S, Leonetti, C, Torri, V, Tinazzi, A, Liberati, A.Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ. 1998;316 (7140):1275–1285.
117.Bergmans, DC, Bonten, MJ, Gaillard, CA.Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med. 2001;164 (3):382–388.
118.de Jonge, E, Schultz, MJ, Spanjaard, L.Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet. 2003;362 (9389):1011–1016.
119.de Smet, AM, Kluytmans, JA, Cooper, BS.Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med. 2009;360 (1):20–31.
120.Karas, JS, Stanbury, JB.Fatal radiation syndrome from an accidental nuclear excursion. N Engl J Med. 1965;272:755–761.
121.Gale, RP.Immediate medical consequences of nuclear accidents. Lessons from Chernobyl. JAMA. 1987;258 (5):625–628.
122.International Atomic Energy Agency. The Radiation Accident at the Irradiation Facility in Nesvizh. IAEA STI/PUB/1010. Vienna: International Atomic Energy Agency; 1996.
123.Coleman, CN, Blakely, WF, Fike, JR.Molecular and cellular biology of moderate-dose (1-10 Gy) radiation and potential mechanisms of radiation protection: report of a workshop at Bethesda, Maryland, December 17-18, 2001. Radiat Res. 2003;159 (6):812–834.
124.Moulder, JE, Cohen, EP.Radiation-induced multi-organ involvement and failure: the contribution of radiation effects on the renal system. BJR Suppl. 2005;27:82–88.
125.Moghissi, ES, Korytkowski, MT, DiNardo, MAmerican Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32 (6):1119–1131.
126.Bernard, GR, Vincent, JL, Laterre, PFRecombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344 (10):699–709.
127.Vinsonneau, C, Camus, C, Combes, A, Hemodiafe Study Group. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet. 2006;368 (9533):379–385.
128.Clement, S, Braithwaite, SS, Magee, MFAmerican Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27 (2):553–591.
129.Wiener, RS, Wiener, DC, Larson, RJ.Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300 (8):933–944.
130.Comi, RJ.Glucose control in the intensive care unit: a roller coaster ride or a swinging pendulum? Ann Intern Med. 2009;150 (11):809–811.
131.Finfer, S, Chittock, DR, Su, SYNICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360 (13):1283–1297.
132.Inzucchi, SE, Siegel, MD.Glucose control in the ICU—how tight is too tight? N Engl J Med. 2009;360 (13):1346–1349.
133.Berger, ME, Sadoff, RL.Psychological support of radiation-accident patients, families, and staff. In: Ricks RC, Berger ME, O’Hara FM, eds. The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims. Boca Raton, FL: Pantheon Press; 2002:191-200.
134.Devereaux, AV, Dichter, JR, Christian, MDTask Force for Mass Critical Care. Definitive care for the critically ill during a disaster: a framework for allocation of scarce resources in mass critical care: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL. Chest. 2008;133 5(Suppl)51S–66S.
135.Gostin, L.Public health strategies for pandemic influenza: ethics and the law. JAMA. 2006;295 (14):1700–1704.
136.Persad, G, Wertheimer, A, Emanuel, EJ.Principles for allocation of scarce medical interventions. Lancet. 2009;373 (9661):423–431.
137.Emanuel, EJ, Wertheimer, A.Public health. Who should get influenza vaccine when not all can? Science. 2006;312 (5775):854–855.
138.White, DB, Katz, MH, Luce, JM, Lo, B.Who should receive life support during a public health emergency? Using ethical principles to improve allocation decisions. Ann Intern Med. 2009;150 (2):132–138.
139.Tabery, J, Mackett, CW IIIUniversity of Pittsburgh Medical Center Pandemic Influenza Task Force's Triage Review Board. Ethics of triage in the event of an influenza pandemic. Disaster Med Public Health Prep. 2008;2 (2):114–118.
140.Sandel, M.Justice: What's the Right Thing to Do? New York: Farrar, Straus & Giroux; 2009.
141.Fink, SL.Worst case: rethinking tertiary triage protocols in pandemics and other health emergencies. Crit Care. 2010;14 (1):103.
142.Coleman, CN, Knebel, AR, Hick, JL.Scarce resources for nuclear detonation: project overview and challenges. Disaster Med Public Health Prep. 2011;5(Suppl 1)S13–S19.
143.Qaseem, A, Snow, V, Shekelle, PClinical Efficacy Assessment Subcommittee of the American College of Physicians. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008;148 (2):141–146.
144.Curado, MPSB, Neto, C, Helou, S.Psychological aspects of the radiation-accident in Goiania: a general overview on victims and population. In: Ricks RC, Berger ME, O’Hara M, eds. The Medical Basis for Radiation Accident Preparedness III: The Psychological Perspective. New York: Elsevier; 1991:143-154.
145.Havenaar, J, Rumyantzeva, G, Kasyanenko, A.Health effects of the Chernobyl disaster: illness or illness behavior? A comparative general health survey in two former Soviet regions. Environ Health Perspect. 1997;105(Suppl 6)1533–1537.
146.Pastel, RH.Radiophobia: long-term psychological consequences of Chernobyl. Mil Med. 2002;167 2(Suppl)134–136.
148.DiGiovanni, C JrDomestic terrorism with chemical or biological agents: psychiatric aspects. Am J Psychiatry. 1999;156 (10):1500–1505.
149.Pynoos, RS, Goenjian, AK, Steinberg, AM.A public mental health approach to the postdisaster treatment of children and adolescents. Child Adolesc Psychiatr Clin N Am. 1998;7 (1):195–210, x.
150.Upton, AC.Radiation injury. In: Goldman L, Ausiello D, eds. Goldman's Cecil Medicine. 23rd ed. Philadelphia: Saunders Elsevier.; 2008:90-96.
151.Tochner, ZA, Lehavi, O, Glatstein, E.Radiation bioterrorism. In: Kasper DL, Fauci AS, Longo D, eds, et al. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2005:1294-1300.
155.Planning guidance for protection and recovery following radiological dispersal device (RDD) and improvised nuclear device (IND) incidents, DHS/FEMA, Z-RIN 1660-za02. http://ogcms.energy.gov/73fr45029.pdf. Published August 1, 2008. Accessed June 16, 2011.
163.Waeckerle, JF, Seamans, S, Whiteside, MTask Force of Health Care and Emergency Services Professionals on Preparedness for Nuclear, Biologiccal, and Chemical Incidents. Executive summary: developing objectives, content, and competencies for the training of emergency medical technicians, emergency physicians, and emergency nurses to care for casualties resulting from nuclear, biological, or chemical incidents. Ann Emerg Med. 2001;37 (6):587–601.
164.Homeland Security Council Interagency Policy Coordination Subcommittee for Preparedness & Response to Radiological and Nuclear Threats. Planning guidance for response to a nuclear detonation. http://remm.nlm.gov/planning-guidance.pdf. Published January 16, 2009. Accessed June 16, 2011.
165.Becker, SM, Middleton, SA.Improving hospital preparedness for radiological terrorism: perspectives from emergency department physicians and nurses. Disaster Med Public Health Prep. 2008;2 (3):174–184.
166.Veenema, TG, Walden, B, Feinstein, N, Williams, JP.Factors affecting hospital-based nurses' willingness to respond to a radiation emergency. Disaster Med Public Health Prep. 2008;2 (4):224–229.
167.Clark, RC, Mayer, RE.e-Learning and the Science of Instruction: Proven Guidelines for Consumers and Designers of Multimedia Learning. San Francisco: Pfeiffer/John Wiley & Sons; 2008.
168.Oak Ridge Institute for Science and Education (ORISE)/Radiation Emergency Assistance Center/Training Site. (REACT/TS). http://orise.orau.gov/reacts. Accessed August 19, 2009.
171.Mettler, FA, Guskova, AK, Gusev, IA.Medical Management of Radiation Accidents. 2nd ed. Albuquerque: University of New Mexico; 2001.
172.Waller, E, Millage, K, Blakely, WF.Overview of hazard assessment and emergency planning software of use to RN first responders. Health Phys. 2009;97 (2):145–156.
173.Radiation Event Medical Management (REMM). Guidance for health care providers. http://remm.nlm.gov. Accessed June 16, 2011.
178.Fliedner, TM, Chao, NJ, Bader, JL.Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation Workshop. Stem Cells. 2009;27 (5):1205–1211.
181.Coleman, CN, Hrdina, C, Bader, JL.Medical response to a radiologic/nuclear event: integrated plan from the Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services. Ann Emerg Med. 2009;53 (2):213–222.